Evidence map›Paper›PMID 34413305›Full record

ArticleNature communications2021

Sumoylation regulates the assembly and activity of the SMN complex.

Giulietta M Riboldi, Irene Faravelli, Takaaki Kuwajima, Nicolas Delestrée, Georgia Dermentzaki, Mariangels De Planell-Saguer, Paola Rinchetti, Le Thi Hao, Christine C Beattie, Stefania Corti and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. DDX20: A Multifunctional Complex Protein.Molecules (Basel, Switzerland) · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Spinal muscular atrophy.Nature reviews. Disease primers · 2022
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Giulietta M Riboldi *Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.ORCID 0000-0003-0322-5718
Irene Faravelli *Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
Takaaki KuwajimaCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.ORCID 0000-0002-8398-3131
Nicolas DelestréeCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
Georgia DermentzakiCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
Mariangels De Planell-SaguerCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
Paola RinchettiCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
Le Thi HaoDepartment of Neuroscience, Ohio State University, Columbus, OH, USA.
Christine C BeattieDepartment of Neuroscience, Ohio State University, Columbus, OH, USA.
Stefania CortiDino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Milan, Italy.ORCID 0000-0001-5425-969X
Serge PrzedborskiCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
George Z MentisCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
Francesco LottiCenter for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA. fl2219@cumc.columbia.edu.ORCID 0000-0002-5104-9088
Columbia University · USUniversity of Milan · ITThe Ohio State University · USAOL (United States) · USColumbia University Irving Medical Center · US

Funding

Mechanisms of Central Synaptic Dysfunction in SMAR01NS078375 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2012 to 2026
$6.6M
Mechanisms of synaptic loss by the classical complement pathway in motor circuit development and diseaseR01AA027079 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MENTIS, GEORGE Z · 2018 to 2022
$3.2M
SMN post-translational modification in Spinal Muscular AtrophyR21NS101575 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOTTI, FRANCESCO · 2017 to 2018
$440k
NIAAA NIH HHS R01 AA027079NINDS NIH HHS R01 NS078375NINDS NIH HHS R21 NS101575
6 · The paper itself

Abstract

SMN is a ubiquitously expressed protein and is essential for life. SMN deficiency causes the neurodegenerative disease spinal muscular atrophy (SMA), the leading genetic cause of infant mortality. SMN interacts with itself and other proteins to form a complex that functions in the assembly of ribonucleoproteins. SMN is modified by SUMO (Small Ubiquitin-like Modifier), but whether sumoylation is required for the functions of SMN that are relevant to SMA pathogenesis is not known. Here, we show that inactivation of a SUMO-interacting motif (SIM) alters SMN sub-cellular distribution, the integrity of its complex, and its function in small nuclear ribonucleoproteins biogenesis. Expression of a SIM-inactivated mutant of SMN in a mouse model of SMA slightly extends survival rate with limited and transient correction of motor deficits. Remarkably, although SIM-inactivated SMN attenuates motor neuron loss and improves neuromuscular junction synapses, it fails to prevent the loss of sensory-motor synapses. These findings suggest that sumoylation is important for proper assembly and function of the SMN complex and that loss of this post-translational modification impairs the ability of SMN to correct selective deficits in the sensory-motor circuit of SMA mice.

Indexed as

SumoylationAnimalsAnimals, Genetically ModifiedCells, CulturedDisease Models, AnimalHumansMiceMotor NeuronsMuscular Atrophy, SpinalNeurodegenerative DiseasesRibonucleoproteins, Small NuclearSMN Complex ProteinsSynapsesZebrafishRibonucleoproteins, Small NuclearSMN Complex Proteins

Identifiers

PMID34413305
PMCPMC8376998
OpenAlexW3194958315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.